Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2010-019359-23-IT
EUCTR2010-019359-23-IT
Active, not recruiting
Not Applicable

Randomized,controlled,open study to evaluate the response to r-TPA therapy vs clinical standard therapy in patients affected by ictus at awakening coming in ER within 3 hours from symptoms compare. - ND

FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR0 sitesMarch 22, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionspatients affected by ictus at awakening coming in ER within 3 hours from symptoms compareMedDRA version: 9.1Level: LLTClassification code 10042244
DrugsACTILYSE*IV FL 20MG+FL 20MLACTILYSE*IV FL 50MG+FL 50ML

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
patients affected by ictus at awakening coming in ER within 3 hours from symptoms compare
Sponsor
FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 22, 2010
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR

Eligibility Criteria

Inclusion Criteria

  • •patients aged between 18 and 80 years old; diagnosis of ischemic ictus with exclusion by TC of bleeding; neurologic dificit evaluable with NIHSS (\= 3, \= 25\);no sponstaneous improvement; symptoms onset \< 3 hours; etc.
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •patients allergic to one or more of the composes of the drug; patients affected by mild or severe renal impairment GFR/eGFR \< 60mL/min; patients unable to perform RM; patients with severe claustrophobia.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 3
A Clinical Study to Evaluate The Efficacy of Yuktaratha Yoga Basti in Sciatica.Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system
CTRI/2023/11/059862Dr Sachin Govindrao Tike
Active, not recruiting
Phase 4
Study to evaluate the efficacy and safety of salmon protein hydrolyate in whey protein isolate powder to improve hemoglobin and serum ferritin in anaemic patientsHealth Condition 1: null- Anemia
CTRI/2014/02/004433Hofseth Biocare AS48
Recruiting
Not Applicable
A clinical trial to study the efficacy of daily versus twice weekly therapy with oral calcitriol for controlling secondary hyperparathyroidsim in pre-dialysis CKD patients.
CTRI/2011/12/002263AIIMS50
Recruiting
Phase 4
The efficacy of angiotensin receptor neprilysin inhibitor in patients after transcatheter aortic valve implantation.
JPRN-jRCT1031220344Kitahara Hideki84
Not yet recruiting
Phase 3
A study of Prasrini taila administration through nasal and through anus in treatment of Cervical spondylosis.
CTRI/2018/10/015990ational Institute of Ayurveda Jaipur